MDCO - The Medicines Company to Announce Second Quarter 2019 Financial Results on July 24
The Medicines Company (NASDAQ: MDCO) will host a conference call and audio webcast on Wednesday, July 24, 2019 at 8:30 a.m. EDT to discuss its second quarter 2019 financial results and operational developments.
The conference call may be accessed by telephone as follows:
U.S./Canada: |
(877) 407-0312 |
International: |
(201) 389-0899 |
Conference ID: |
13692457 |
A live audio webcast of the conference call may be accessed in the Investors section of The Medicines Company website.
A taped replay of the conference call will be available after the call concludes, and may be accessed by telephone as follows:
U.S./Canada: |
(877) 660-6853 |
International: |
(201) 612-7415 |
Conference ID: |
13692457 |
An archived webcast will be also be available after the call concludes.
About The Medicines Company
The Medicines Company is a biopharmaceutical company whose purpose is to halt the deadly progression of atherosclerosis and the cardiovascular risk created by high levels of LDL-C, or bad cholesterol. Our team is focused on transformational solutions that address the daily challenges that patients, physicians and payers confront in cardiovascular care. The Company is headquartered in Parsippany, New Jersey. For more information, please visit www.themedicinescompany.com and follow us on Twitter @MDCONews and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190717005011/en/
Investor Relations
Krishna Gorti, M.D.
Vice President, Investor Relations
973 290 6122
krishna.gorti@themedco.com
Media Inquiries
Michael Blash
Vice President, Communications
973 290 6100
michael.blash@themedco.com